SYBE — SYBLEU Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for SYBLEU, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K/A | 10-K/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0.004 | 0.012 | 0.012 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 0.004 | 0.092 | 0.068 | 0.161 |
| Operating Profit | -0.004 | -0.088 | -0.056 | -0.149 |
| Total Net Non Operating Interest Income / Expense | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.004 | -0.08 | -0.245 | -0.18 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.004 | -0.102 | -0.245 | -0.18 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.004 | -0.102 | -0.245 | -0.18 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.004 | -0.102 | -0.245 | -0.18 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0 | -0.01 | -0.024 | -0.017 |
| Dividends per Share |